Age-related increase in resistance to acute Trypanosoma cruzi infection in rats is associated with an appropriate antibody response

Scandinavian Journal of Immunology

Volumn 58, Issue 2, 2003, Pages 173-179

  Pascutti, M F ^a   Bottasso, O A ^a   Hourquescos, M C ^b   Wietzerbin, J ^c   Revelli, S ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; HOST RESISTANCE; MALE; NONHUMAN; PARASITEMIA; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTOZOAL INFECTION; RAT; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

AGE FACTORS; ANIMALS; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; HEMOLYSIS; IMMUNITY, NATURAL; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE; NITRITES; PARASITEMIA; RATS; STATISTICS, NONPARAMETRIC; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042848854     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01262.x     Document Type: Article

References (32)

1. Kirchhoff LV. American trypanosomiasis (Chagas' disease) - a tropical disease now in the United States. N Engl J Med 1993;329: 639-44.
2. Brener Z, Krettli AU. Immunology of Chagas' disease. In: Wyler DJ, ed. Modern Parasite Biology - Cellular, Immunological and Molecular Aspects. New York: W.H. Freeman and Co., 1982, 247-61.
3. Reed SG. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J Immunol 1988;140:4342-7.
4. Revelli S, Davila H, Ferro ME et al. Experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon gamma. Microbiol Immunol 1995;39:275-82.
5. Torrico F, Heremans H, Rivera MT, Marck EV, Billiau A, Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 1991;146: 3626-32.
6. Golden JM, Tarleton RL. Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp Parasitol 1991;72:391-402.
7. Muñoz Fernandez MA, Fernandez M, Fresno M. Synergism between tumor necrosis factor α and interferon γ on macrophage activation against intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 1992;22:301-7.
8. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FG. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995;63:4862-7.
9. Revelli SS, Amerio N, Moreno HS, Valenti JL, Balbarrey H, Morini J. Enfermedad de Chagas crónica en la rata. Características serológicas, electrocardiográficas e histopatológicas. Medicina (B Aires) 1980;40:69-76.
10. Davila HO, Revelli S, Moreno HS et al. Infection with Trypanosoma cruzi during pregnancy in rats and a decrease in chronic myocardial lesions in their infected offspring. Am J Trop Med Hyg 1994;50:506-11.
11. Revelli S, Moreno H, Berra H et al. Influencia de la edad de la rata en la evolucion de la infeccion con Trypanosoma cruzi. Medicina (B Aires) 1987;47:360-6.
12. Makinodan T. Patterns of age-related immunologic changes. Nutr Rev 1995;53:S27-34.
13. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and nitrate in biological fluids. Anal Biochem 1982;126:131-8.
14. Krettli AU, Weisz-Carrington P, Nussenzweig RS. Membrane-bound antibodies of bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement mediated lysis. Clin Exp Immunol 1979;37:416-23.
15. Giclas PC. Complement, classical pathway evaluation. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: Wiley, 2000, 13.1.1-4.
16. Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996;271:1728-30.
17. Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996;271:1726-8.
18. Rowe J, Macaubas C, Monger TM et al. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect Immun 2000;68:3873-7.
19. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur J Immunol 1992;22: 2501-6.
20. Petray P, Castaños-Velez E, Grinstein S, Örn A, Rottenberg ME. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol Lett 1995;47:121-6.
21. Vespa GNR, Cunha FQ, Silva JS. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 1994;62:5177-82.
22. Hölscher C, Köhler G, Müller U, Mossmann H, Schaub GA, Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 1998;66:1208-15.
23. Black CM, Israelski DM, Suzuki Y, Remington JS. Effect of recombinant tumor necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi. Immunology 1989;68:570-4.
24. Castaños-Veles E, Maerlan S, Osorio LM et al. Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect Immun 1998;66:2960-8.
25. Olivares Fontt E, De Baetselier P, Heirman C, Thielemans K, Lucas R, Vray B. Effects of granulocyte-macrophage colony-stimulating factor and tumor necrosis alpha on Trypanosoma cruzi trypomastigotes. Infect Immun 1998;66:2722-7.
26. Ropert C, Gazzinelli RT. Signalling of immune system cells by glycosylphosphatidylinositol (GPI) anchor and related structures derived from parasitic protozoa. Curr Opin Microbiol 2000;3:395-403.
27. Abrahamsohn IA, Coffman RL. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol 1995;155:3955-63.
28. Russo M, Starobinas N, Ribeiro dos Santos R, Minoprio PO, Honteyberie-Joskowicz M. Susceptible mice present higher macrophage activation than resistant mice during infection with myotropic strains of Trypanosoma cruzi. Parasite Immunol 1989;11:385-95.
29. Umekita LF, Mota I. How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi? Braz J Med Biol Res 2000;33:253-8.
30. 75Se-methionine labelled Trypanosoma cruzi blood trypomastigotes: opsonization by chronic infection serum facilitates killing in spleen and liver. Clin Exp Immunol 1982;48:754-7.
31. Tarlinton D. Germinal centers: form and function. Curr Opin Immunol 1998;10:245-51.
32. Fearon DT, Manders P, Wagner SD. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 2001;293:248-50.